David J. Rudnick
Senior Vice President
David Rudnick has over 20 years of investor relations and investment banking experience, both in the healthcare field and as a generalist, working with a wide array of US, European and Asian companies. He has tailored strategic plans to raise the profiles of client companies across the capital markets spectrum using the language of Wall Street to convey the drivers of valuation to the investment community. He has advised on capital markets strategies to optimize market value that incorporate best practices procedures.
Prior to joining Rx Communications, David was a senior securities analyst at Morgan Stanley on their #1-ranked research team and advised on portfolio optimization for the firm’s buy side institutional investors. He was also selected to work with the firm’s senior officers on strategic planning projects.
Previous to that, David was a convertibles analyst at Salomon Brothers where he authored a macroeconomic report on healthcare equity securities.
Prior to joining Salomon Brothers, David was an investment banker at Prudential Securities where specialized in healthcare and then developed new products off of the equity capital markets desk. David began his career at Butcher and Singer where he worked in healthcare investment banking and executed IPO’s, private placements, M&A transactions, fairness opinions and real estate MLP’s.
David has a BA in Economics from the University of Pennsylvania and an MBA from the Wharton School.
Rx Communications Group, LLC
555 Madison Avenue 5th Floor New York, NY 10022